Diffusion kurtosis imaging study of prostate cancer: Preliminary findings

Journal of Magnetic Resonance Imaging

Volumn 40, Issue 3, 2014, Pages 723-729

  Tamura, Chiharu ^a   Shinmoto, Hiroshi ^a   Soga, Shigeyoshi ^a   Okamura, Teppei ^a   Sato, Hiroki ^a   Okuaki, Tomoyuki ^b   Pang, Yuxi ^c   Kosuda, Shigeru ^a   Kaji, Tatsumi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b PHILIPS RESEARCH LABORATORIES   (Germany)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

benign prostatic hyperplasia; diffusion; kurtosis; magnetic resonance imaging; prostate cancer

Indexed keywords

GADODIAMIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION KURTOSIS IMAGING; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HISTOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; VERY ELDERLY; CANCER GRADING; CANCER STAGING; PATHOLOGY; PROCEDURES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY;

AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84906093990     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24379     Document Type: Article

References (44)

1. Jemal A, Center MM, Desantis C, Ward EM,. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907.
2. Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012; 61: 1079-1092.
3. Brawley OW,. Trends in prostate cancer in the United States. J Natl Cancer Inst Monogr 2012; 45: 152-156.
4. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localized disease. Eur Urol 2011; 59: 61-71.
5. Eskicorapci SY, Baydar DE, Akbal C, et al. An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer. Eur Urol 2004; 45: 444-448.
6. Passoni NM, Di Trapani E, Suardi N, et al. Clinical and diagnostic assessment for therapeutic decisions in prostate cancer. Q J Nucl Med Mol Imaging 2012; 56: 321-330.
7. McSherry SA, Levy F, Schiebler ML, Keefe B, Dent GA, Mohler JL,. Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging. J Urol 1991; 146: 85-89.
8. Schnall MD, Pollack HM,. Magnetic resonance imaging of the prostate gland. Urol Radiol 1990; 12: 109-114.
9. Jager GJ, Ruijter ET, van de Kaa CA, et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997; 203: 645-652.
10. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006; 239: 784-792.
11. Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012; 22: 746-757.
12. Oto A, Kayhan A, Jiang Y, et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 2010; 257: 715-723.
13. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005; 21: 258-262.
14. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S,. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007; 25: 146-152.
15. Reinsberg SA, Payne GS, Riches SF, et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 2007; 188: 91-98.
16. Yoshimitsu K, Kiyoshima K, Irie H, et al. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 2008; 27: 132-139.
17. Tan CH, Wei W, Johnson V, Kundra V,. Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 2012; 199: 822-829.
18. Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K,. Diffusion kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005; 53: 1432-1440.
19. Lu H, Jensen JH, Ramani A, Helpern JA,. Three-dimensional characterization of non-gaussian water diffusion in human using diffusion kurtosis imaging. NMR Biomed 2006; 19: 236-247.
20. Jensen JH, Helpern JA,. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed 2010; 23: 698-710.
21. Li H, Sugimura K, Kaji Y, et al. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. AJR Am J Roentgenol 2006; 186: 729-742.
22. Ishida J, Sugimura K, Okizuka H, et al. Benign prostatic hyperplasia: value of MR imaging for determining histologic type. Radiology 1994; 190: 329-331.
23. Kaji Y, Kuroda K, Maeda T, et al. Anatomical and metabolic assessment of prostate using a 3-Tesla MR scanner with a custom-made external transceive coil: healthy volunteer study. J Magn Reson Imaging 2007; 25: 517-526.
24. Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22: 275-282.
25. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16: 172-178.
26. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16: 172-178.
27. Koh DM, Collins DJ,. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-1635.
28. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 2008; 28: 720-726.
29. Jensen JH, Falangola MF, Hu C, et al. Preliminary observations of increased diffusional kurtosis in human brain following recent cerebral infarction. NMR Biomed 2011; 24: 452-457.
30. Helpern JA, Adisetiyo V, Falangola MF, et al. Preliminary evidence of altered gray and white matter microstructural development in the frontal lobe of adolescents with attention-deficit hyperactivity disorder: a diffusional kurtosis imaging study. J Magn Reson Imaging 2011; 33: 17-23.
31. Raab P, Hattingen E, Franz K, Zanella FE, Lanfermann H,. Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences. Radiology 2010; 254: 876-881.
32. Rosenkrantz AB, Sigmund EE, Johnson G, et al. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. Radiology 2012; 264: 126-135.
33. Niendorf T, Dijkhuizen RM, Norris DG, van Lookeren Campagne M, Nicolay K,. Biexponential diffusion attenuation in various states of brain tissue: implications for diffusion-weighted imaging. Magn Reson Med 1996; 36: 847-857.
34. Yablonskiy DA, Bretthorst GL, Ackerman JJ,. Statistical model for diffusion attenuated MR signal. Magn Reson Med 2003; 50: 664-669.
35. Yablonskiy DA, Sukstanskii AL,. Theoretical models of the diffusion weighted MR signal. NMR Biomed 2010; 23: 661-681.
36. Bennett KM, Schmainda KM, Bennett RT, Rowe DB, Lu H, Hyde JS,. Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med 2003; 50: 727-734.
37. Mulkern RV, Gudbjartsson H, Westin CF, et al. Multi-component apparent diffusion coefficients in human brain. NMR Biomed 1999; 12: 51-62.
38. Kwee TC, Galban CJ, Tsien C, et al. Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas. NMR Biomed 2010; 23: 179-187.
39. Mulkern RV, Barnes AS, Haker SJ, et al. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging 2006; 24: 563-568.
40. Shinmoto H, Oshio K, Tanimoto A, et al. Biexponential apparent diffusion coefficients in prostate cancer. Magn Reson Imaging 2009; 27: 355-359.
41. Shinmoto H, Tamura C, Soga S, et al. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer. AJR Am J Roentgenol 2012; 199: W496-W500.
42. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M,. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168: 497-505.
43. Acton FS,. Numerical methods that works, 2nd ed. Washington, DC: The Mathematical Association of America; 1990. p 253.
44. Oshio K,. Reliability of bi-exponential parameter estimation. In: Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, 2012. p 3583.